These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9537353)

  • 1. Delayed profound thrombocytopenia after c7E3 Fab (abciximab) therapy.
    Jenkins LA; Lau S; Crawford M; Keung YK
    Circulation; 1998 Mar; 97(12):1214-5. PubMed ID: 9537353
    [No Abstract]   [Full Text] [Related]  

  • 2. Acute profound thrombocytopenia after C7E3 Fab (abciximab) therapy.
    Berkowitz SD; Harrington RA; Rund MM; Tcheng JE
    Circulation; 1997 Feb; 95(4):809-13. PubMed ID: 9054735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abciximab-associated profound thrombocytopenia: therapy with immunoglobulin and platelet transfusion.
    Kereiakes DJ; Essell JH; Abbottsmith CW; Broderick TM; Runyon JP
    Am J Cardiol; 1996 Nov; 78(10):1161-3. PubMed ID: 8914883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute profound thrombocytopenia following C7E3 Fab (Abciximab) therapy: case reports, review of the literature and implications for therapy.
    Jubelirer SJ; Koenig BA; Bates MC
    Am J Hematol; 1999 Jul; 61(3):205-8. PubMed ID: 10398314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe delayed thrombocytopenia associated with abciximab (ReoPro) therapy.
    Reddy MS; Carmody TJ; Kereiakes DJ
    Catheter Cardiovasc Interv; 2001 Apr; 52(4):486-8. PubMed ID: 11285605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abciximab-induced acute profound thrombocytopenia postpercutaneous coronary intervention.
    Golden T; Ghazala S; Wadeea R; Junna S
    BMJ Case Rep; 2017 Jul; 2017():. PubMed ID: 28710245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombocytopenia associated with c7E3 Fab (abciximab).
    Schell DA; Ganti AK; Levitt R; Potti A
    Ann Hematol; 2002 Feb; 81(2):76-9. PubMed ID: 11907786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute profound thrombocytopenia without bleeding complications after re-administration of abciximab.
    Nguyen N; Salib H; Mascarenhas DA
    J Invasive Cardiol; 2001 Jan; 13(1):56-8. PubMed ID: 11146690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute profound thrombocytopenia after c7E3 Fab therapy.
    Ferrari E; Thiry M; Touati C; Gibelin P; Baudouy M
    Circulation; 1997 Nov; 96(10):3809-10. PubMed ID: 9396511
    [No Abstract]   [Full Text] [Related]  

  • 10. The importance of differentiating ReoPro (c7E3 abciximab) induced thrombocytopenia from heparin-induced thrombocytopenia.
    Davidson SJ; Turner N; Clague JR; Oldershaw PJ; Burman JF
    Thromb Haemost; 1999 Nov; 82(5):1560-1. PubMed ID: 10595660
    [No Abstract]   [Full Text] [Related]  

  • 11. Acute profound thrombocytopenia after abciximab therapy during coronary angioplasty.
    Joseph T; Marco J; Gregorini L
    Clin Cardiol; 1998 Nov; 21(11):851-2. PubMed ID: 9825202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute profound thrombocytopenia without bleeding complications after abciximab administration.
    Elmi F; Oza R; Mascarenhas DA
    J Invasive Cardiol; 1999 May; 11(5):313-5. PubMed ID: 10745539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Profound delayed thrombocytopenia presenting 16 days after Abciximab (Reopro®) administration.
    Webb GJ; Swinburn JM; Grech H
    Platelets; 2011; 22(4):302-4. PubMed ID: 21526887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abciximab-induced thrombocytopenia.
    Griffiths C; Fisher M
    QJM; 2002 Sep; 95(9):635-6. PubMed ID: 12205341
    [No Abstract]   [Full Text] [Related]  

  • 15. Acute profound thrombocytopenia following abciximab therapy.
    Bishara AI; Hagmeyer KO
    Ann Pharmacother; 2000; 34(7-8):924-30. PubMed ID: 10928405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fatal delayed thrombocytopenia following abciximab therapy.
    McCorry RB; Johnston P
    J Invasive Cardiol; 2006 Jun; 18(6):E173-4. PubMed ID: 16775895
    [No Abstract]   [Full Text] [Related]  

  • 17. Thrombocytopenia and glycoprotein IIb-IIIa receptor antagonists.
    Stiegler HM; Fischer Y; Steiner S
    Lancet; 1999 Apr; 353(9159):1185. PubMed ID: 10210005
    [No Abstract]   [Full Text] [Related]  

  • 18. Profound thrombocytopenia caused by abciximab infusion following.
    Daley B; Miranda D; Kalra A; Pease D
    Minn Med; 2014 Oct; 97(10):48-9. PubMed ID: 25651641
    [No Abstract]   [Full Text] [Related]  

  • 19. Coronary stenting and use of abciximab.
    Mohl W; Menges M; Hennen B; Schieffer H; Zeitz M
    Lancet; 1998 Oct; 352(9136):1312. PubMed ID: 9788485
    [No Abstract]   [Full Text] [Related]  

  • 20. Images in cardiovascular medicine. Abciximab-associated pseudothrombocytopenia.
    Holmes MB; Kabbani S; Watkins MW; Battle RW; Schneider DJ
    Circulation; 2000 Feb; 101(8):938-9. PubMed ID: 10694535
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.